A durable and protective TB vaccine in humans is thought to require the induction of polyfunctional effector memory CD4+ T cell populations that respond rapidly in the lung23 and/or long-lived CD4+ T cells that exhibit a less-differentiated central memory phenotype24–28. Here, CD4 is linked to tuberculosis.